Sarepta Therapeutics (NASDAQ: SRPT) plans to present seven posters at the 27th Annual Neuromuscular Study Group Scientific Meeting, scheduled for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE